Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis

Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis

Mechanisms of host–pathogen interactions resulting in immunopathological responses upon human Campylobacter jejuni infection are not completely understood, but the recent availability of murine infection models mimicking key features of campylobacteriosis helps solving this dilemma. During a screen...

Full description

Bibliographic Details
Main Authors:	Markus M. Heimesaat, Anna-Maria Schmidt, Soraya Mousavi, Ulrike Escher, Nicole Tegtmeyer, Silja Wessler, Gabriele Gadermaier, Peter Briza, Dirk Hofreuter, Stefan Bereswill, Steffen Backert
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-11-01
Series:	Gut Microbes
Subjects:	campylobacteriosis secondary abiotic il-10−/- mouse model pro-inflammatory immune responses m24 peptidase family xaa-pro aminopeptidase pepp host–pathogen interaction
Online Access:	http://dx.doi.org/10.1080/19490976.2020.1770017

Similar Items

The Role of Campylobacter Jejuni in Campylobacteriosis
by: M Mehdizadeh, et al.
Published: (2009-03-01)

Comparative genomics of Campylobacter jejuni from clinical campylobacteriosis stool specimens
by: Bilal Djeghout, et al.
Published: (2022-12-01)

Novel Clinical <i>Campylobacter jejuni</i> Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis
by: Soraya Mousavi, et al.
Published: (2020-03-01)

Vitamin D in Acute Campylobacteriosis–Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model
by: Soraya Mousavi, et al.
Published: (2019-09-01)

Gestundete Zeit
by: Matthias Goldmann

Biochemical Characterization of a Novel Alkaline-Tolerant Xaa-Pro Dipeptidase from <i>Aspergillus phoenicis</i>
by: Zixing Dong, et al.
Published: (2023-11-01)

Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in <i>Campylobacter jejuni</i> Infected Microbiota-Depleted IL-10<sup>−/−</sup> Mice
by: Soraya Mousavi, et al.
Published: (2020-12-01)

Expression of recombinant Omp18 and MOMP of Campylobacter jejuni and the determination of their suitability as antigens for serological diagnosis of campylobacteriosis in animals
by: Sergey Borovikov, et al.
Published: (2023-01-01)

Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis
by: Stefan Bereswill, et al.
Published: (2021-06-01)

Global epidemiology of campylobacteriosis and the impact of COVID-19
by: Fang Liu, et al.
Published: (2022-11-01)

Viability and gene transcription of Campylobacter jejuni in infant milk formulas
by: Roberta Torres de Melo, et al.
Published: (2019-07-01)

Viability and gene transcription of Campylobacter jejuni in infant milk formulas
by: Roberta Torres de Melo, et al.
Published: (2019-07-01)

Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by <i>Campylobacter jejuni</i>
by: Fábia D. Lobo de Sá, et al.
Published: (2021-08-01)

Disease alleviating effects following prophylactic lemon and coriander essential oil treatment in mice with acute campylobacteriosis
by: Soraya Mousavi, et al.
Published: (2023-03-01)

Prevalencia de Campylobacteriosis y Trichomoniasis en toros del Municipio Rosario de Perijá, Estado Zulia, Venezuela
by: Astrid Arismendi de Pino, et al.
Published: (2010-07-01)

Socioeconomic Status and Campylobacteriosis, Connecticut, USA, 1999–2009
by: Kelley Bemis, et al.
Published: (2014-07-01)

Therapeutic Oral Application of Carvacrol Alleviates Acute Campylobacteriosis in Mice Harboring a Human Gut Microbiota
by: Minnja S. Foote, et al.
Published: (2023-02-01)

Poultry Culling and Campylobacteriosis Reduction among Humans, the Netherlands
by: Ingrid H.M. Friesema, et al.
Published: (2012-03-01)

Molecular Targets in <i>Campylobacter</i> Infections
by: Markus M. Heimesaat, et al.
Published: (2023-02-01)

Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis—Results from a Preclinical Placebo-Controlled Intervention Study
by: Markus M. Heimesaat, et al.
Published: (2021-05-01)

MLST genotypes of Campylobacter jejuni isolated from broiler products, dairy cattle and human campylobacteriosis cases in Lithuania
by: Sigita Ramonaite, et al.
Published: (2017-06-01)

Source attributed case-control study of campylobacteriosis in New Zealand
by: R.J. Lake, et al.
Published: (2021-02-01)

Antibiotic Resistance in the Alternative Lifestyles of Campylobacter jejuni
by: Daise Aparecida Rossi, et al.
Published: (2021-05-01)

ES-PPDA: an efficient and secure privacy-protected data aggregation scheme in the IoT with an edge-based XaaS architecture
by: Quan Chen, et al.
Published: (2022-07-01)

The Host-Specific Intestinal Microbiota Composition Impacts <i>Campylobacter coli</i> Infection in a Clinical Mouse Model of Campylobacteriosis
by: Markus M. Heimesaat, et al.
Published: (2020-09-01)

Peroral Clove Essential Oil Treatment Ameliorates Acute Campylobacteriosis—Results from a Preclinical Murine Intervention Study
by: Stefan Bereswill, et al.
Published: (2021-03-01)

A meta‐analysis of case‐control studies examining sporadic campylobacteriosis in Australia and New Zealand from 1990 to 2016
by: Liana Varrone, et al.
Published: (2020-08-01)

Duck Liver–associated Outbreak of Campylobacteriosis among Humans, United Kingdom, 2011
by: Muhammad Abid, et al.
Published: (2013-08-01)

Oral treatment of human gut microbiota associated IL-10−/− mice suffering from acute campylobacteriosis with carvacrol, deferoxamine, deoxycholic acid, and 2-fucosyl-lactose
by: Soraya Mousavi, et al.
Published: (2024-01-01)

Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): bovine genital campylobacteriosis
by: EFSA Panel on Animal Health and Welfare (AHAW), et al.
Published: (2017-10-01)

Campylobacter: Asymptomatic campylobacteriosis and Guillain Barré syndrome in Mexico
by: Luis Del Carpio-Orantes
Published: (2022-07-01)

A Novel 6G Conversational Orchestration Framework for Enhancing Performance and Resource Utilization in Autonomous Vehicle Networks
by: Sonia Shahzadi, et al.
Published: (2023-08-01)

Hydrologic Modeling as a Service (HMaaS): A New Approach to Address Hydroinformatic Challenges in Developing Countries
by: Michael A. Souffront Alcantara, et al.
Published: (2019-10-01)

Roles of viable but non-culturable state in the survival of Campylobacter jejuni
by: Leticia Silva Santos, et al.
Published: (2023-03-01)

Spatio-temporal outbreaks of campylobacteriosis and the role of fresh-milk vending machines in the Czech Republic: A methodological study
by: Lukáš Marek, et al.
Published: (2017-11-01)

Resveratrol Alleviates Acute <i>Campylobacter jejuni</i> Induced Enterocolitis in a Preclinical Murine Intervention Study
by: Markus M. Heimesaat, et al.
Published: (2020-11-01)

Non food-related risk factors of campylobacteriosis in Canada: a matched case-control study
by: André Ravel, et al.
Published: (2016-09-01)

Estimation Activity And Partial Purification Of Leucine Amino Peptidase (Lap) In Patients Wiith Diabetic Nephropathy
by: Baghdad Science Journal
Published: (2012-12-01)

Comparison of Source Attribution Methodologies for Human Campylobacteriosis
by: Maja Lykke Brinch, et al.
Published: (2023-05-01)

Environmental and demographic risk factors for campylobacteriosis: do various geographical scales tell the same story?
by: Arsenault Julie, et al.
Published: (2012-11-01)